VISABL-VT trial launches with landmark first-in-human procedure
Imricor Medical Systems has initiated its VISABL-VT clinical trial with the world’s first MRI-guided ventricular ablation, performed at Amsterdam University Medical Centre (AUMC) using Imricor’s NorthStar Mapping System.
The milestone marks the first ventricular and first left-sided ablation using real-time MRI — a leap forward in treating complex arrhythmias. Unlike X-ray, MRI provides full-field visualization of heart structures, blood vessels, and the treatment’s real-time impact on tissue.
“This is a huge milestone,” said Imricor CEO Steve Wedan, noting the company’s founding goal in 2006 to enable safer and more precise ablation procedures with MRI-compatible technology.
Key Highlights:
- MRI reveals treatment effects on cardiac tissue during ablation
- Enhanced anatomical detail and real-time guidance reduce reliance on X-ray
- Procedure enabled by multidisciplinary collaboration and years of preparation
- Patient outcome: procedure successful, arrhythmia eliminated
“We are extremely proud to be the first in the world to treat complex arrhythmias in an MRI scanner,” said Dr. Cor Allaart, AUMC Professor of Electrophysiology.
Follow MEDWIRE.AI for innovation in interventional cardiology.
